Abstract
Glucocorticoid studies of infarct size illustrate features of more general interest for clinical trials. A point of note is the close relationship of studies in animals to those in humans.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Libby P, Maroko PR, Bloor CH, Sobel BE, Braunwald E: Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest. 52: 599–606, 1973.
Morrison J, Reduto L, Pizzarello R, Geller K, Maley T, Gullota S: Modification of myocardial injury in man by corticosteroid administration. Circulation 51: I200–203, 1976.
Roberts R, de Melli V, Sobel BE: Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 53: I204–206, 1976.
Bulkley BH, Roberts WC: Steroid therapy during acute myocardial infarction. Am J Med 56: 244–250, 1974.
Green RM, Cohen J, DeWeese JA: Short-term use of corticoids after experimental myocardial infarction: effects on ventricular function and infarct healing. Circulation 50: I101–103, 1974.
Editor information
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Dern, P.L. (1984). Steroid Treatment of Acute Myocardial Infarction: Some Implications for Clinical Trials in General. In: Morganroth, J., Moore, E.N. (eds) Interventions in the Acute Phase of Myocardial Infarction. Developments in Cardiovascular Medicine, vol 41. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3819-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3819-2_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3821-5
Online ISBN: 978-1-4613-3819-2
eBook Packages: Springer Book Archive